CYP1A1 and colon carcinoma: The HDAC inhibitors butyrate, panobinostat and vorinostat enhanced TCDD-mediated induction of Cyp1a1/CYP1A1 in the murine YAMC and human Caco-2 colon carcinoma cell lines, respectively.